Managing fever in children with a single antipyretic

Area of Science:

• Pediatrics
• Pharmacology
• Evidence-Based Medicine

Background:

• Combined antipyretic use in children is common but lacks clinical benefit.
• This practice may exacerbate
• fever phobia
• and increase the risk of medication dosing errors.
• Current guidelines recommend using a single antipyretic for pediatric fever management.

Purpose of the Study:

• To address the prevalent practice of combining antipyretics in children.
• To debunk myths surrounding pediatric fevers and their treatment.
• To review and promote evidence-based best practices for fever management in children.

Main Methods:

• Literature review of current research and national guidelines on pediatric fever treatment.
• Analysis of the risks associated with combined antipyretic use.
• Discussion of the concept of
• fever phobia
• and its impact on parental behavior.

Main Results:

• There is no evidence to support the clinical benefit of using combination antipyretics for children's fevers.
• Combined use increases the potential for medication errors and worsens parental anxiety about fever.
• Evidence-based recommendations support the use of a single antipyretic agent.

Conclusions:

• Nurses play a crucial role in educating parents and healthcare professionals about safe fever management.
• Promoting evidence-based practices can lead to safer drug administration and reduce the incidence of
• fever phobia
• and associated risks.
• Adherence to guidelines for single antipyretic use is essential for pediatric patient safety.